Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
-7.87%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
-$100M
Cap. Flow %
-0.83%
Top 10 Hldgs %
34.84%
Holding
1,453
New
30
Increased
610
Reduced
359
Closed
38

Sector Composition

1 Real Estate 59.2%
2 Technology 9.45%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NKTR icon
1201
Nektar Therapeutics
NKTR
$896M
$2K ﹤0.01%
36
NKTX icon
1202
Nkarta
NKTX
$148M
$2K ﹤0.01%
180
NRIX icon
1203
Nurix Therapeutics
NRIX
$697M
$2K ﹤0.01%
152
NUVL icon
1204
Nuvalent
NUVL
$5.63B
$2K ﹤0.01%
125
PGEN icon
1205
Precigen
PGEN
$1.21B
$2K ﹤0.01%
708
PMVP icon
1206
PMV Pharmaceuticals
PMVP
$77.9M
$2K ﹤0.01%
132
RAPT icon
1207
RAPT Therapeutics
RAPT
$220M
$2K ﹤0.01%
13
RPTX icon
1208
Repare Therapeutics
RPTX
$74.7M
$2K ﹤0.01%
127
-5,745
-98% -$90.5K
SGMO icon
1209
Sangamo Therapeutics
SGMO
$157M
$2K ﹤0.01%
498
STOK icon
1210
Stoke Therapeutics
STOK
$1.19B
$2K ﹤0.01%
126
TBPH icon
1211
Theravance Biopharma
TBPH
$687M
$2K ﹤0.01%
215
TIL icon
1212
Instil Bio
TIL
$173M
$2K ﹤0.01%
19
VNDA icon
1213
Vanda Pharmaceuticals
VNDA
$265M
$2K ﹤0.01%
191
YMAB icon
1214
Y-mAbs Therapeutics
YMAB
$390M
$2K ﹤0.01%
149
KLRS
1215
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.2M
$2K ﹤0.01%
10
TVRD
1216
Tvardi Therapeutics, Inc. Common Stock
TVRD
$286M
$2K ﹤0.01%
5
GTHX
1217
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
145
KNTE
1218
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$2K ﹤0.01%
127
NSTG
1219
DELISTED
NanoString Technologies, Inc.
NSTG
$2K ﹤0.01%
156
TCDA
1220
DELISTED
Tricida, Inc. Common Stock
TCDA
$2K ﹤0.01%
207
AERI
1221
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$2K ﹤0.01%
102
INBX
1222
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2K ﹤0.01%
111
JBIO
1223
Jade Biosciences, Inc. Common Stock
JBIO
$249M
$1K ﹤0.01%
2
BCAB icon
1224
BioAtla
BCAB
$38M
$1K ﹤0.01%
103
BCYC
1225
Bicycle Therapeutics
BCYC
$491M
$1K ﹤0.01%
58